Applied Therapeutics, Inc. - Common Stock $0.0001 par value per share (APLT)

Historical Holders from Q2 2019 to Q1 2025

Symbol
APLT on Nasdaq
CUSIP
03828A101
Type / Class
Equity / Common Stock $0.0001 par value per share
Shares outstanding
119M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
115M
Holdings value
$98.5M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
118
Number of buys
76
Number of sells
-70
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Applied Therapeutics, Inc. - Common Stock $0.0001 par value per share (APLT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vestal Point Capital, LP 9.9% $5.75M 11.5M Vestal Point Capital, LP Dec 31, 2024
BlackRock, Inc. 8% $4.65M 9.3M BlackRock, Inc. Dec 31, 2024
Schonfeld Strategic Advisors LLC 7.54% $4.38M 8.77M Schonfeld Strategic Advisors LLC Dec 31, 2024
Alyeska Investment Group, L.P. 5.76% $3.35M 6.71M Alyeska Investment Group, L.P. Dec 31, 2024
Venrock Healthcare Capital Partners III, L.P. 10.1% $2.51M 5.01M Venrock Healthcare Capital Partners III, L.P. Jan 30, 2025
PERCEPTIVE ADVISORS LLC 2.4% $1.43M 2.86M Perceptive Advisors LLC Dec 31, 2024
MORGAN STANLEY 2.5% $1.43M 2.86M Morgan Stanley Jan 31, 2025
FRANKLIN RESOURCES INC 1.7% $1M 2M Franklin Resources, Inc. Dec 31, 2024
JANUS HENDERSON GROUP PLC 0% $17.9K 35.8K JANUS HENDERSON GROUP PLC Dec 31, 2024

Institutional Holders of Applied Therapeutics, Inc. - Common Stock $0.0001 par value per share (APLT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 462K $226K -$13.5K $0.49 6
2024 Q4 115M $98.5M -$63M $0.86 118
2024 Q3 113M $961M +$78.2M $8.50 132
2024 Q2 103M $482M +$37M $4.67 96
2024 Q1 94M $639M +$220M $6.80 90
2023 Q4 61.4M $206M +$29.8M $3.35 81
2023 Q3 43M $107M +$29.1M $2.49 53
2023 Q2 31.5M $40.3M +$15.8M $1.28 37
2023 Q1 19.3M $15.6M +$123K $0.81 33
2022 Q4 19.4M $14.7M -$2.56M $0.76 34
2022 Q3 22.7M $21.1M -$3.11M $0.93 37
2022 Q2 26.6M $25.2M +$12.9M $0.95 44
2022 Q1 12.3M $26M -$34.5M $2.11 65
2021 Q4 14.9M $133M -$7.91M $8.95 63
2021 Q3 15.1M $251M -$6.06M $16.60 67
2021 Q2 15.4M $319M +$9.97M $20.78 67
2021 Q1 14M $263M +$48.1M $18.76 65
2020 Q4 11.7M $257M -$1.66M $22.01 64
2020 Q3 12.2M $253M -$3.37M $20.76 62
2020 Q2 11.3M $407M +$70.3M $36.15 68
2020 Q1 9.64M $315M +$155M $32.69 60
2019 Q4 4.99M $136M +$71.2M $27.28 45
2019 Q3 2.39M $26.3M +$2.24M $10.99 27
2019 Q2 2.17M $17.9M +$17.9M $8.24 12